Structure-activity relationships of adenosines with heterocyclic N6-substituents

被引:34
|
作者
Ashton, T. D. [1 ]
Aumann, Kylee M. [2 ,3 ]
Baker, Stephen P. [4 ]
Schiesser, Carl H. [2 ,3 ]
Scammells, Peter J. [1 ]
机构
[1] Monash Univ, Victorian Coll Pharm, Dept Med Chem, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic 3010, Australia
[4] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
基金
澳大利亚研究理事会;
关键词
adenosine; A(1)AR agonist;
D O I
10.1016/j.bmcl.2007.10.028
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two series of N-6-substituted adenosines with monocyclic and bicyclic N-6 substituents containing a heteroatom were synthesized in good yields. These derivatives were assessed for their affinity ([H-3]CPX), potency, and intrinsic activity (cAMP accumulation) at the A, adenosine receptor in DDT1 MF-2 cells. In the monocyclic series, the N-6-tetrahydrofuran-3-yl and thiolan-3-yl adenosines (1 and 26, respectively) were found to possess similar activities, whereas the corresponding selenium analogue 27 was found to be more potent. A series of nitrogen containing analogues showed varying properties, N-6-((3R)-1-benzyloxycarbonylpyrrolidin-3-yl)adenosine (30) was the most potent at the AIAR; IC50 = 3.2 nM. In the bicyclic series, the effect of a 7-azabicyclo[2.2.1]heptan-2-yl substituent in the N-6-position was explored. N6- (7-Azabicyclo[2.2.1] heptan-2-yl)adeno sine (38) proved to be a reasonably potent A, agonist (K-i = 51 nM, IC50 = 35 nM) while further substitution on the 7 ''-nitrogen with tert-butoxycarbonyl (31, IC50 = 2.5 nM) and 2-bromobenzyloxycarbonyl (34, IC50 = 9.0 nM) gave highly potent A(1)AR agonists. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6779 / 6784
页数:6
相关论文
共 50 条
  • [2] Synthesis and Biological Evaluation of Adenosines with Heterobicyclic and Polycyclic N6-Substituents as Adenosine A1 Receptor Agonists
    Gosling, Joshua I.
    Baker, Stephen P.
    Haynes, John M.
    Kassiou, Michael
    Pouton, Colin W.
    Warfe, Lyndon
    White, Paul J.
    Scammells, Peter J.
    CHEMMEDCHEM, 2012, 7 (07) : 1191 - 1201
  • [3] Structure-activity relationships of estrogen derivatives as aromatase inhibitors. Effects of heterocyclic substituents
    Numazawa, Mitsuteru
    Komatsu, Sachiko
    Tominaga, Takako
    Yamashita, Kouwa
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (09) : 1304 - 1309
  • [4] STRUCTURE-ACTIVITY ANALYSIS OF N6-SUBSTITUTED ADENOSINES IDENTIFIES POTENT CORONARY VASODILATORS
    OLSSON, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 191 : 41 - MEDI
  • [5] Adenosine receptor ligands with oxygenated N6-substituents
    Hutchinson, SA
    Baker, SP
    Scammells, PJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) : 933 - 936
  • [6] C2,N6-DISUBSTITUTED ADENOSINES - SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS
    TRIVEDI, BK
    BRUNS, RF
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) : 1667 - 1673
  • [7] STRUCTURE-ACTIVITY RELATIONSHIPS OF N-ALKYL AND HETEROCYCLIC ANALOGS OF HEMICHOLINIUM-3
    BENZ, FW
    LONG, JP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1969, 168 (02): : 315 - &
  • [8] SYNTHETIC PENICILLINS - HETEROCYCLIC ANALOGS OF AMPICILLIN - STRUCTURE-ACTIVITY RELATIONSHIPS
    HATANAKA, M
    ISHIMARU, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (09) : 978 - 984
  • [9] α-N-Heterocyclic Thiosemicarbazone Derivatives as Potential Antitumor Agents: A Structure-Activity Relationships Approach
    Matesanz, Ana I.
    Souza, Pilar
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (12) : 1389 - 1396
  • [10] 2-amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists:: 1.: Structure-activity relationships and optimization of heterocyclic substituents
    Slee, Deborah H.
    Chen, Yongsheng
    Zhang, Xiaohu
    Moorjani, Manisha
    Lanier, Marion C.
    Lin, Emily
    Rueter, Jaimie K.
    Williams, John P.
    Lechner, Sandra M.
    Markison, Stacy
    Malany, Siobhan
    Santos, Mark
    Gross, Raymond S.
    Jalali, Kayvon
    Sai, Yang
    Zuo, Zhiyang
    Yang, Chun
    Castro-Palomino, Julio C.
    Crespo, Maria I.
    Prat, Maria
    Gual, Silvia
    Diaz, Jose-Luis
    Saunders, John
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1719 - 1729